Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

NCT05139056 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

36

Enrollment

OTHER

Sponsor class

Stopped Safety issues

Conditions

Currently Only Enrolling Glioblastoma Patients at First Recurrence

Interventions

BIOLOGICAL: Neural Stem Cells-expressing CRAd-S-pk7
PROCEDURE: Resection

Sponsor

City of Hope Medical Center

Collaborators

[object Object]